On May 2, 2023, BIOGENERA’s shareholders’ meeting approved the 2022 budget; the new Board of Directors (BOD) was also appointed on this occasion. Dr. Thibaud Eckenschwiller has been appointed chairman of the board of BIOGENERA. Dr. Eckenschwiller is a top manager in the pharmaceutical industry with extensive international experience. Dr. Eckenschwiller is Senior Life Sciences C-suite Executive globally, with extensive experience in organizing and managing Big Pharma and Specialty Care Pharma Companies. He has served as CFO or CEO in Novartis, Ypsen, Zambon and Medichem.